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Monday, February 22, 2010 321abut this static picture alone cannot depict the protein movements that must oc-
cur during ion transport. To address this issue, we have utilized fluorine NMR
to monitor substrate-induced conformational changes in ClC-ec1. We show that
substrate-driven conformational change is not constrained to the Cl- permeation
pathway alone, and that the ClC-ec1 subunit interface participates in protein
movement. Furthermore, removal of the protein’s Hþ transport ability does
not eliminate the Hþ-dependent protein movement observed in the intact anti-
porter. Finally, we observe that a ClC-ec1 ‘‘channel-like’’ mutant is not subject
to the same substrate-dependent conformational changes that occur in the ClC-
ec1 transporters. Together, these results provide new insight into conforma-
tional change in ClC-ec1 and lay an essential foundation for future studies
on ClC-ec1 protein dynamics.
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Duchenne Muscular Dystrophy (DMD) is the most common human X-linked
disease affecting 1/3,500 male births. DMD patients suffer from severe, pro-
gressive muscle wasting with clinical symptoms first detected between 2 to 5
years of age. As the disease progresses patients are confined to a wheelchair
in their early teens and die in their early twenties from cardiopulmonary failure.
There is currently no effective treatment or cure for DMD. DMD patients and
mdx mice (the mouse model for DMD) have mutations in the dystrophin gene
that result in an absence of the dystrophin protein. Dystrophin is a 427 kDa pro-
tein located under the sarcolemma on the inner cytoplasmic membrane of skel-
etal and cardiac muscle cells and provides structural and functional integrity to
muscle. Although therapies have been developed that target skeletal muscle
disease, increasing evidence suggests correcting the cardiomyopathy is critical
to the survival of DMD patients. As the cardiomyopathy progresses, the hearts
of DMD patients and mdx mice exhibit arrhythmias, conduction abnormalities
and left ventricular dilation. Recent studies have shown that the chloride ion
channel ClC-3, a candidate protein responsible for volume-regulated chloride
channels in heart, plays a critical cardioprotective role against the development
of hypertrophy and failure (J Mol. Cell. Cardiol. 2009 Jul 15. [Epub ahead of
print]).Using transgenic mice including heart specific ClC-3 knockout mdx
mice, echocardiography and electrophysiology, we analyzed the role of ClC-
3 in modulating cardiac disease progression in dystrophic mice. Our prelimi-
nary results indicate ClC-3 may be a major modifier of cardiac disease progres-
sion in mdx mice and targeting ClC-3 expression or function may provide
a novel therapeutic approach for the treatment of dilated cardiomyopathy in
DMD (supported by 3P20RR015581 from the National Center for Research
Resources).
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To investigate the pore structure of the cystic fibrosis transmembrane conduc-
tance regulator (CFTR) channel, we performed a systematic pore probing on
CFTR channel pore with a series of small aromatic carboxylic acids, including
their positional isomers, e.g., 9-anthracene carboxylic acid (9-AC) and 1-an-
thracene carboxylic acid (1-AC).
Small compounds presumably interacting the channel protein with a few points
are sensitive to structural changes of the binding site. However such low affin-
ity blockers show fast - intermediate blocking kinetics which give us the overall
affinity, but not on- and off- rates separately. To overcome this problem, we de-
veloped an iterative simulation method to estimate the on- and off- rate con-
stants in the 9-AC or 1-AC block from the single channel amplitude distribu-
tion.
The newly developed Amplitude Distribution Analysis (ADA) program first
generated a single-channel current according to the given kinetic scheme and
added a Gaussian noise to the currents for mimicking the background noise.
The simulated currents were low-pass filtered and digitized at the same fre-
quencies as those in the experiments and binned into an amplitude histogram.Then the program repeats a direct likelihood comparison between the simulated
and experimental current amplitude distributions to find the best fitted values
for the blocking kinetic parameters.
The ADA program showed that the off-rate of 1-AC block is 3-fold slower than
that of 9-AC and the on-rate of 1-AC is ~3-fold faster than that of 9-AC. The
voltage-dependences of on- and off- rates of 1-AC are similar to those of 9-AC,
respectively. These suggest that 1-AC and 9-AC block CFTR channel by bind-
ing to a common binding site which should be modeled by a combination of
a positive charge tightly surrounded by hydrophobic residues.
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The Cystic fibrosis transmembrane conductance regulator (CFTR) chloride
channel plays an important role in salt and water transport across epithelia
and defective function due to mutations in the CFTR gene cause cystic fibrosis
(CF). The glycine-to-aspartate missense mutation at position 551 (G551D) is
the third most common CF-associated mutation and G551D-CFTR is character-
ized by a very low open probability despite of its normal trafficking to the
plasma membrane.
Numerous small molecules have been shown to increase the activity of G551D-
CFTR presumably by binding to the CFTR protein. Among the many G551D-
CFTR potentiators, a bioflavonoid found in legumes, genistein is perhaps the
most extensively studied. More recently it was reported that a component of
the spice turmeric, curcumin strongly activated G551D-CFTR. However, The
mechanism through which these compounds increase G551D-CFTR activity
is still unclear. On the other hand, we have previously reported that anthra-
cene-9-carboxylate (9-AC) showed an inhibitory effect and an potentiation ef-
fect on CFTR channels by binding to two chemically distinct sites for each ef-
fect (Ai et al, 2004).
In this study, we made a functional probing on genistein-potentiated G551D-
CFTR and curcumin-potentiated G551D-CFTR using 9-AC and its positional
isomer, anthracene-1-carboxylate (1-AC). In wild type- (WT-) CFTR, 9-AC in-
duced a large voltage-independent enhancement and a voltage-dependent inhi-
bition in the whole-cell (WC) current. 1-AC induced a smaller enhancement
and a larger voltage-dependent block in WT-CFTR WC currents in compared
with 9-AC. In the other hand, both 9-AC and 1-AC induced only a weak volt-
age-dependent inhibitions in genistein-potentiated G551D-CFTR WC currents
whereas, in curcumin-potentiated G551D-CFTR WC currents, 9-AC and 1-AC
induced similar effects to those in WT-CFTR. These suggest that curcumin and
genistein potentiated G551D-CFTR via different mechanisms. We speculate
that genistein-potentiated and curcumin-potentiated G551D-CFTRs might
have different protein conformations.
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CFTR chloride channels comprise two nucleotide binding domains (NBD1 and
NBD2).Mutations (for example,G551D) that impairCFTR function result in the
lethal genetic disease cystic fibrosis (CF). It’s established that the opening and
closing of CFTR are mainly controlled by ATP binding and hydrolysis respec-
tively in NBD2 while ATP binding at NBD1 can modulate the stability of the
open state. Using a non-hydrolytic ligand MgPPi, we locked open CFTR chan-
nels with mutations at NBD1. We found that two W401 mutations significantly
increased the lock-open time (W401F: 7253s; W401Y: 5156s; WT: 2752s).
These gain-of-function mutations are unexpected since the W401-equivalent
residue Y1219 in NBD2 can be effectively replaced by tryptophan but not phe-
nylalanine. As the ATP molecule bound in NBD1 may interact with NBD2’s
signature sequence (LSHGH), we extended our study to this region. We found
that reverting the histidine residue 1348 to the canonical glycine (H1348G) sim-
ilarly stabilized the lock-open state (t=6758s). Once W401F, H1348G, or
W401F/H1348G mutations were incorporated into G551D channels which no
longer respond to ATP, the mutant channels becomeATP-responsive with basal
activity increased by ~10-fold for W401F/G551D-, ~4-fold for H1348G/
5G551D-, and ~25-fold for W401F/H1348G/G551D-channels. The increased
